Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NPI 1932135068
NPI deactivated

1932135068

1932135068 was paid $748K by Medicaid between Jan 2018 and Dec 2024, across 10 billing codes. Its largest line is J7507, Tacrolimus, immediate release, oral, 1 mg — 34% of everything it billed.

33Billing provider info1932135068
33aNPI1932135068
33bProvider type—
28Total paid$748K
24GClaims64,190
24DCodes billed10
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201812,719$206K
201911,847$172K
202011,360$139K
20219,149$97K
20228,284$49K
20236,830$62K
2024incomplete4,001$22K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J7507 Tacrolimus, immediate release, oral, 1 mg 34% 13,207 11,062 $255K
J7518 Mycophenolic acid, oral, 180 mg 32% 3,772 3,258 $241K
J7517 Mycophenolate mofetil, oral, 250 mg 21% 7,473 6,670 $154K
Q0511 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period 3.9% 11,022 10,194 $29K
Q0512 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period 3.8% 20,510 10,423 $29K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 3.7% 7,655 6,983 $28K
J7515 Cyclosporine, oral, 25 mg 1.4% 399 354 $10K
J7520 Sirolimus, oral, 1 mg <1% 29 26 $2K
Q0510 Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant <1% 91 91 $340.00
J7500 Azathioprine, oral, 50 mg <1% 32 24 $143.21

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.